Search - tctmd.com

Displaying 21 - 40 of 946

Sort: Relevancy | Date

Presentation TCT 2025

Case 2: Long Recurrent Diffuse Coronary ISR: The Case for Brachytherapy

Presenter: Stephen G. Ellis

October 27, 2025

Presentation TCT 2025

Case 1: The Sweet Spot for DCB: Focal Multilayer Coronary ISR

Presenter: Luiz F. Ybarra

October 27, 2025

News Conference News TCT 2025

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

Michael O'Riordan

October 26, 2025

Presentation TCT 2025

Case: AVVIGO+ AGENT in ISR

Presenter: Matheen A. Khuddus

October 26, 2025

Presentation TCT 2025

TCT 194: A Comparative Analysis of Clinical Outcomes in Patients with In-Stent Restenosis Undergoing Advanced Lesion Preparation Prior to Percutaneous Coronary Intervention with Drug Coated Balloons

Presenter: Haseeb Ur Rahman

October 26, 2025

Presentation TCT 2025

TCT 191: Optical Coherence Tomography-Guided or Intravascular Ultrasound-Guided PCI for In-Stent Restenosis Lesions in the OCTIVUS Trial

Presenter: Kyeong-Won Seo

October 26, 2025

Presentation TCT 2025

TCT 195: Long-term Follow up of Patients with Non-obstructive Coronary Atherosclerosis

Presenter: Ota Hlinomaz

October 26, 2025

Presentation TCT 2025

TCT 192: Prediction of 2-Year Target Lesion Failure by Final OCT Minimal Stent Area in Cases of In-Stent Restenosis

Presenter: Cheuk Yin Wong

October 26, 2025

Presentation TCT 2025

TCT 193: Trends in the use of Intravascular imaging in In-stent Restenosis Percutaneous Coronary Intervention

Presenter: Nihit Shah

October 26, 2025

Presentation TCT 2025

TCT 190: Optical Coherence Tomography Outcomes in Patients with In-stent Restenosis Treated with Drug-Eluting Stent vs Drug-Coated Balloon

Presenter: Hang Long Li

October 26, 2025

Presentation TCT 2025

TCT 186: Management of In-Stent Restenosis in Coronary Vein Grafts: Revascularization Strategies and Outcomes

Presenter: Oludamilola Akinmolayemi

October 26, 2025

Presentation TCT 2025

TCT 185: The Incidence of In-Stent Restenosis Among Patients with Cancer

Presenter: Akram Mahdi

October 26, 2025

Presentation TCT 2025

TCT 184: Impact of Intravascular Imaging on Clinical Outcomes in Patients with In-Stent Restenosis: A Single-Centre Observational Study

Presenter: Nihit Shah

October 26, 2025

Presentation TCT 2025

TCT 189: Follow-up of Flow-Reserve-Guided Treatment for In-Stent Restenosis of Drug-Eluting Coronary Stents

Presenter: Kornel Kakonyi

October 26, 2025

Presentation TCT 2025

TCT 179: In-Stent Restenosis in Chronic Kidney Failure: Long-Term Outcomes Following Drug-Coated Balloons Versus Thin-Strut Drug-Eluting Stents

Presenter: Rafal Adam Januszek

October 26, 2025

Presentation TCT 2025

TCT 178: Use of the AGENT Paclitaxel-Coated Balloon in the United States Shortly After FDA Approval: Early Results from the AGENT Post-Approval Study

Presenter: Christina Lalani

October 26, 2025

Presentation TCT 2025

TCT 180: Paclitaxel-Coated Balloon versus Uncoated Balloon for Coronary In-Stent Restenosis in Patients with Acute Coronary Syndromes: A Subanalysis of the AGENT IDE Trial

Presenter: Neal S. Kleiman

October 26, 2025

Presentation TCT 2025

TCT 182: Impact of Lesion Preparation Strategy on the Efficacy of Paclitaxel Coated Balloon for Coronary In-stent Restenosis: A Subgroup Analysis of the AGENT IDE Randomized Trial

Presenter: Aditya Mantha

October 26, 2025

Presentation TCT 2025

TCT 181: Efficacy and Safety of Coronary Angioplasty Using a Paclitaxel-Coated vs Uncoated Balloon in Patients with In-Stent Restenosis Stratified by Restenosis Risk: A Subanalysis of the AGENT IDE

Presenter: Prakriti Gaba

October 26, 2025

Presentation TCT 2025

TCT 175: Contemporary Trends for the Treatment of In-Stent Restenosis in the United States: Insights from the CathPCI Registry

Presenter: Jennifer Rymer

October 26, 2025

Advertisement

Case 2: Long Recurrent Diffuse Coronary ISR: The Case for Brachytherapy

Case 1: The Sweet Spot for DCB: Focal Multilayer Coronary ISR

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

Case: AVVIGO+ AGENT in ISR

TCT 194: A Comparative Analysis of Clinical Outcomes in Patients with In-Stent Restenosis Undergoing Advanced Lesion Preparation Prior to Percutaneous Coronary Intervention with Drug Coated Balloons

TCT 191: Optical Coherence Tomography-Guided or Intravascular Ultrasound-Guided PCI for In-Stent Restenosis Lesions in the OCTIVUS Trial

TCT 195: Long-term Follow up of Patients with Non-obstructive Coronary Atherosclerosis

TCT 192: Prediction of 2-Year Target Lesion Failure by Final OCT Minimal Stent Area in Cases of In-Stent Restenosis

TCT 193: Trends in the use of Intravascular imaging in In-stent Restenosis Percutaneous Coronary Intervention

TCT 190: Optical Coherence Tomography Outcomes in Patients with In-stent Restenosis Treated with Drug-Eluting Stent vs Drug-Coated Balloon

TCT 186: Management of In-Stent Restenosis in Coronary Vein Grafts: Revascularization Strategies and Outcomes

TCT 185: The Incidence of In-Stent Restenosis Among Patients with Cancer

TCT 184: Impact of Intravascular Imaging on Clinical Outcomes in Patients with In-Stent Restenosis: A Single-Centre Observational Study

TCT 189: Follow-up of Flow-Reserve-Guided Treatment for In-Stent Restenosis of Drug-Eluting Coronary Stents

TCT 179: In-Stent Restenosis in Chronic Kidney Failure: Long-Term Outcomes Following Drug-Coated Balloons Versus Thin-Strut Drug-Eluting Stents

TCT 178: Use of the AGENT Paclitaxel-Coated Balloon in the United States Shortly After FDA Approval: Early Results from the AGENT Post-Approval Study

TCT 180: Paclitaxel-Coated Balloon versus Uncoated Balloon for Coronary In-Stent Restenosis in Patients with Acute Coronary Syndromes: A Subanalysis of the AGENT IDE Trial

TCT 182: Impact of Lesion Preparation Strategy on the Efficacy of Paclitaxel Coated Balloon for Coronary In-stent Restenosis: A Subgroup Analysis of the AGENT IDE Randomized Trial

TCT 181: Efficacy and Safety of Coronary Angioplasty Using a Paclitaxel-Coated vs Uncoated Balloon in Patients with In-Stent Restenosis Stratified by Restenosis Risk: A Subanalysis of the AGENT IDE

TCT 175: Contemporary Trends for the Treatment of In-Stent Restenosis in the United States: Insights from the CathPCI Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content